• LAST PRICE
    3.2250
  • TODAY'S CHANGE (%)
    Trending Down-0.0850 (-2.5680%)
  • Bid / Lots
    2.9000/ 3
  • Ask / Lots
    3.2000/ 3
  • Open / Previous Close
    3.2100 / 3.3100
  • Day Range
    Low 3.1100
    High 3.2700
  • 52 Week Range
    Low 1.6600
    High 8.5650
  • Volume
    77,171
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.31
TimeVolumePRLD
09:37 ET8753.21
09:42 ET5003.2
09:46 ET2003.24
10:15 ET7333.25
10:20 ET1003.27
10:36 ET25783.25
10:40 ET8583.24
10:42 ET1003.26
10:45 ET2003.24
10:47 ET1003.21
10:49 ET1003.25
10:51 ET2003.22
10:54 ET6003.21
11:00 ET1003.22
11:02 ET1003.23
11:05 ET1003.24
11:07 ET1003.245
11:12 ET3473.24
11:14 ET1003.24
11:16 ET9823.24
11:20 ET1003.24
11:21 ET1003.24
11:23 ET2003.2366
11:25 ET2123.24
11:27 ET1003.21
11:38 ET4003.2296
11:39 ET10003.2687
11:41 ET1003.26
11:43 ET6003.24
11:45 ET1003.26
11:48 ET1003.26
11:52 ET5313.26
11:56 ET3003.24
11:57 ET4293.24
11:59 ET1003.24
12:03 ET1003.22
12:06 ET1673.24
12:10 ET2003.24
12:15 ET8413.25
12:17 ET1003.21
12:21 ET6053.21
12:28 ET1003.21
12:30 ET3003.23
12:44 ET1003.22
12:48 ET5003.235
12:55 ET1003.235
01:31 ET2643.235
01:33 ET4003.24
01:47 ET1003.25
01:49 ET13973.21
02:00 ET5373.18
02:02 ET6453.18
02:09 ET9003.18
02:12 ET3503.17
02:16 ET2003.17
02:18 ET1003.18
02:20 ET4003.1791
02:21 ET10003.17
02:23 ET12053.14
02:30 ET12003.11
02:32 ET20183.2
02:36 ET4823.19
02:41 ET1003.18
02:48 ET1003.18
02:54 ET1003.18
02:59 ET1003.15
03:01 ET1003.15
03:06 ET1343.15
03:08 ET6003.17
03:12 ET3003.15
03:14 ET3003.1583
03:15 ET2003.16
03:17 ET5003.15
03:19 ET1003.1619
03:26 ET11913.15
03:30 ET19353.1403
03:32 ET1003.14
03:35 ET2583.15
03:37 ET4003.15
03:44 ET1033.14
03:48 ET4003.14
03:50 ET2003.1575
03:51 ET6503.18
03:53 ET2003.23
03:55 ET17963.25
03:57 ET8773.22
04:00 ET215393.225
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRLD
Prelude Therapeutics Inc
176.8M
-1.5x
---
United StatesATXS
Astria Therapeutics Inc
172.4M
-2.2x
---
United StatesINMB
INmune Bio Inc
173.2M
-6.3x
---
United StatesTHRX
Theseus Pharmaceuticals Inc
170.7M
-2.9x
---
United StatesIVVD
Invivyd Inc
169.6M
-1.0x
---
United StatesMACK
Merrimack Pharmaceuticals Inc
184.7M
-127.3x
---
As of 2023-12-02

Company Information

Prelude Therapeutics Inc. is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. Its CDK9 program is an essential regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. The Company’s product candidates include PRT1419, PRT2527, PRT3789, and PRT3645. PRT1419 is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1. PRT2527 is a potent and highly selective CDK9 inhibitor. PRT2527 treatment demonstrated robust efficacy in both hematological malignancies and solid tumor models with MYC. PRT3645 is a next-generation CDK4/6 inhibitor. PRT3789 is an IV-administered SMARCA2 degrader. Its pipeline consists of multiple distinct programs spanning methyltransferases, kinases, protein-protein interactions, and targeted protein degraders.

Contact Information

Headquarters
200 Powder Mill RoadWILMINGTON, DE, United States 19803
Phone
302-547-3768
Fax
302-658-3989

Executives

Independent Chairman of the Board
Paul Friedman
President, Chief Medical Officer
Jane Huang
Chief Executive Officer, Founder, Director
Krishna Vaddi
Chief Financial Officer
Laurent Chardonnet
Executive Vice President, Head of Chemistry
Andrew Combs

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$176.8M
Revenue (TTM)
$0.00
Shares Outstanding
54.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.17
Book Value
$4.08
P/E Ratio
-1.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.